Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure allows for effective binding in receptor sites, making it valuable in drug discovery for oncology and inflammatory diseases. The fluorinated biphenyl group enhances metabolic stability and membrane permeability, improving the pharmacokinetic profile of drug candidates. Also employed in the preparation of chiral ligands and catalysts for asymmetric synthesis.